Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Case Report, Medical Science and Practice
Case Report, Microbiology and Immunology
Case Report, Neurosciences and Behavioral Sciences
Commentaries, Neurosciences and Behavioural Sciences
Commentaries, Pharmacotherapy/Pharmaceutical Care
Drug Evaluation and Clinical Trials, Original Research Article
Editorial
Epidemiology and Public Health, Original Research Article
Ethnomedicine and Phytomedicines, Original Research Article
Ethnomedicine and Phytomedicines, Review Article
Medical Science and Practice, Case Report
Medical Science and Practice, Original Research Article
Minireview Pharmacology and Toxicology
Minireview, Pharmacy Profession and Advocacy
Miniview, Pharmaceutical Education
Original Research Article, Drug Evaluation and Clinical Trials
Original Research Article, Drug Research and Development
Original Research Article, Epidemiology and Public Health
Original Research Article, Ethnomedicine and Phytomedicines
Original Research Article, Microbiology and Immunology
Original Research Article, Neurology
Original Research Article, Pharmaceutical Education
Original Research Article, Pharmaceutical Technology and Manufacturing
Original Research Article, Pharmaceutics and Drug Delivery
Original Research Article, Pharmacology and Toxicology
Original Research Article, Pharmacotherapy/Pharmaceutical Care
Original Research Article, Pharmacy Practice
Pharmaceutical Technology and Manufacturing, Original Research Article
Pharmacology and Toxicology, Original Research Article
Pharmacotherapy/Pharmaceutical Care, Case Report
Pharmacotherapy/Pharmaceutical Care, Original Research Article
Pharmacy Practice, Original Research Article
Pharmacy Profession and Advocacy, Original Research Article
Review Article
Review Article, Biochemistry and Biotechnology
Review Article, Medical Devices
Review Article, Neurosciences and Behavioral Sciences
Review Article, Perspective
Review Article, Pharmacotherapy/Pharmaceutical Care
Review Article, Pharmacy Practice
Review, Epidemiology and Public Health
Review, Ethnomedicine and Phytomedicines
Systematic Review, Drug Evaluation and Clinical Trials
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Case Report, Medical Science and Practice
Case Report, Microbiology and Immunology
Case Report, Neurosciences and Behavioral Sciences
Commentaries, Neurosciences and Behavioural Sciences
Commentaries, Pharmacotherapy/Pharmaceutical Care
Drug Evaluation and Clinical Trials, Original Research Article
Editorial
Epidemiology and Public Health, Original Research Article
Ethnomedicine and Phytomedicines, Original Research Article
Ethnomedicine and Phytomedicines, Review Article
Medical Science and Practice, Case Report
Medical Science and Practice, Original Research Article
Minireview Pharmacology and Toxicology
Minireview, Pharmacy Profession and Advocacy
Miniview, Pharmaceutical Education
Original Research Article, Drug Evaluation and Clinical Trials
Original Research Article, Drug Research and Development
Original Research Article, Epidemiology and Public Health
Original Research Article, Ethnomedicine and Phytomedicines
Original Research Article, Microbiology and Immunology
Original Research Article, Neurology
Original Research Article, Pharmaceutical Education
Original Research Article, Pharmaceutical Technology and Manufacturing
Original Research Article, Pharmaceutics and Drug Delivery
Original Research Article, Pharmacology and Toxicology
Original Research Article, Pharmacotherapy/Pharmaceutical Care
Original Research Article, Pharmacy Practice
Pharmaceutical Technology and Manufacturing, Original Research Article
Pharmacology and Toxicology, Original Research Article
Pharmacotherapy/Pharmaceutical Care, Case Report
Pharmacotherapy/Pharmaceutical Care, Original Research Article
Pharmacy Practice, Original Research Article
Pharmacy Profession and Advocacy, Original Research Article
Review Article
Review Article, Biochemistry and Biotechnology
Review Article, Medical Devices
Review Article, Neurosciences and Behavioral Sciences
Review Article, Perspective
Review Article, Pharmacotherapy/Pharmaceutical Care
Review Article, Pharmacy Practice
Review, Epidemiology and Public Health
Review, Ethnomedicine and Phytomedicines
Systematic Review, Drug Evaluation and Clinical Trials
View/Download PDF

Translate this page into:

Original Research Article
Epidemiology and Public Health
2026
:5;
5
doi:
10.25259/AJPPS_2026_005

Knowledge, perception, and disposition of healthcare workers toward malaria vaccine in Obafemi Awolowo University Teaching Hospital Complex (OAUTHC)

Department of Biology, Georgia State University, Atlanta, Georgia, United States.

*Corresponding author: Esther Jumoke Akinye, MPH, Department of Biology, Georgia State University, Atlanta, Georgia, United States. eakinye1@student.gsu.edu

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Akinye EJ. Knowledge, perception, and disposition of healthcare workers toward malaria vaccine in Obafemi Awolowo University Teaching Hospital Complex (OAUTHC). Am J Pharmacother Pharm Sci. 2026:005.

Abstract

Objectives:

This study aims to evaluate the knowledge, perception, and disposition among health professionals towards malaria vaccine at the Obafemi Awolowo University Teaching Hospital Complex (OAUTHC).

The objectives are to: Evaluate the knowledge of health professionals about currently available malaria vaccine, assess the attitude of health professionals towards the recommendation of malaria vaccines to patients and the wider community and explore associations between factors like professional background, years of experience, or access to training resources and knowledge, perceptions, and attitudes towards the malaria vaccine.

Materials And Methods:

A cross-sectional, quantitative study design was employed, with data collected from 154 healthcare professionals at the Obafemi Awolowo University Teaching Hospital Complex (OAUTHC) using a structured questionnaire.

Results:

The findings revealed high awareness of the malaria vaccine among healthcare workers (84.42%). However, about 87% reported less than average knowledge, with only 11.04% having received formal training on the vaccine. While 90.26% of respondents expressed willingness to recommend the vaccine, significant barriers were identified, including a lack of awareness (69.7%), costs (44.7%), and cultural beliefs (38.2%). Statistical analysis indicated significant association between religion and attitude towards the vaccine (P < 0.05).

Conclusion:

The study highlights the need for targeted educational campaigns and training programs to enhance healthcare workers’ knowledge and confidence in malaria vaccination efforts. Addressing systemic barriers such as cost, cultural misconceptions, and infrastructure limitations will be essential for the successful implementation of malaria vaccine programs in Nigeria.

Keywords

Attitude
Healthcare Workers
Knowledge
Malaria
Nigeria
Vaccine

INTRODUCTION

Malaria infection is caused by the Plasmodium species, including Plasmodium falciparum, Plasmodium ovale, Plasmodium malariae, and Plasmodium vivax, transmitted through the bite of an infected female Anopheles mosquito during blood feeding.[1] In severe cases, malaria can lead to bleeding and death if untreated. According to the World Health Organization (WHO), 94% of global malaria cases and 95% of related deaths occur in Africa.[2] In 2023 alone, the WHO reported 263 million cases worldwide, with 597,000 deaths attributed to the disease. Nigeria bore the highest burden, accounting for 30.9% of mortality associated with malaria.[2] The disease also imposes a significant health and economic burden on individuals and the government.[3-7] Beyond healthcare expenses, malaria causes substantial economic losses through lost productivity, missed school days, and reduced workforce participation.[4]

Treatment of malaria in Nigeria involves both traditional and conventional medical approaches.[8] The Nigerian government, in alignment with the WHO guidelines, promotes the use of insecticide-treated nets, indoor residual spraying, intermittent preventive treatment for pregnant women, and anti-malarial drugs such as proguanil, doxycycline, and mefloquine for chemoprophylaxis.[9] Despite these efforts, the persistent endemicity of malaria and the rise of resistance to anti-malarial drugs have highlighted the need for more advanced interventions. However, adherence to these treatment guidelines remains inconsistent, with studies indicating variable implementation at healthcare facilities.[10] Despite decades of coordinated malaria control efforts, progress has stagnated. Since 2012, annual incidence rates have not significantly declined, highlighting the urgency of developing innovative strategies to combat the disease.[11]

The development of the malaria vaccine marks a significant advancement in the fight against malaria. After decades of research, the first malaria vaccine, RTS, S/AS01 (Mosquirix®), was approved by the WHO in 2021.[12] It was shown to reduce incidence and mortality from malaria infection among young children. In the first three stages of clinical trials, the RTS, S vaccine demonstrated efficacy in reducing clinical malaria by 30%, with a good safety profile and cost-effectiveness.[13] However, the vaccine has limitations, particularly its inability to reduce transmission rates or confer herd immunity.[14] A more promising development is the R21/Matrix-M anti-malarial vaccine, which has shown an efficacy of 75%, compared to RTS, S, and has been approved for widespread use.[15] This new vaccine offers hope, though it also does not prevent transmission in endemic areas like Nigeria.

Malaria vaccine rollout in Nigeria began in 2024.[16] While this presents an opportunity to reduce the malaria burden, the success of the vaccination program will depend heavily on the role of healthcare workers in its distribution and administration. Despite the potential of malaria vaccines, challenges related to healthcare workers’ knowledge, perceptions, and attitudes may hinder their adoption and the vaccine’s success. Available studies report that misinformation and vaccine hesitancy are major obstacles.[17] Previous vaccine programs, such as those for polio and coronavirus disease-2019 (COVID-19), faced challenges due to widespread misinformation, resistance, and social and cultural factors.[18]

Healthcare workers’ knowledge of the malaria vaccine is critical, as they are responsible for educating the public and administering the vaccine. However, studies have shown that healthcare workers in Nigeria often lack adequate knowledge about new vaccines and may harbor reservations about their efficacy and safety, which impacts their willingness to administer and recommend them.[19] Previous research on vaccine hesitancy among healthcare workers in Nigeria highlights the importance of addressing concerns and providing comprehensive training and resources to enhance healthcare workers’ confidence in the malaria vaccine.[6]

While there is significant literature on the general burden and management of malaria, a notable gap exists in studies addressing healthcare workers’ knowledge, perceptions, and attitudes toward the malaria vaccine in Nigeria. This research aims to fill this gap by providing an in-depth examination of healthcare workers’ knowledge and attitudes in Nigeria, with a specific focus on Osun State. Understanding these factors will be crucial in predicting vaccine adoption rates and in designing effective public health campaigns.

MATERIALS AND METHODS

Study design

This study is a cross-sectional study measuring the knowledge, attitude, and disposition of healthcare workers to the malaria vaccine at a point in time.[20] This design was chosen as it allows for the observation of gaps in vaccine knowledge and the factors that lead to these outcomes, which will form the basis of intervention design. The study employs both descriptive and analytical approaches to achieve its objectives.

Study setting

This study was a single-center study conducted at the Obafemi Awolowo University Teaching Hospital Complex (OAUTHC) in Osun State, Nigeria. The hospital is a 724-bed, tertiary facility with 6 healthcare units. Its primary medical services include anesthesia and intensive care, oral and maxillofacial surgery, radiology, family medicine, and community health.

Ethical consideration

Ethical approval was sought and obtained from the Ethical Committee of Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria (IRB/IEC/Z0004553) and from the University of Sunderland in London Campus Ethics Committee (ref: 029414). Participants were briefed on the study’s purpose and malaria vaccine, and informed consent was obtained online. The study protocol adhered to standard practices. Confidentiality and anonymity of participants were also maintained.

Target population

The population considered in this study is the healthcare workers at the OAUTHC. The hospital employs about 3,034 clinical staff as of November 2023.[21]

Inclusion criteria

  1. Respondent must be a medical doctor, nurse, pharmacist, or physiotherapist

  2. For pharmacists, respondents must have a Bachelor of Pharmacy or a Doctor of Pharmacy degree

  3. For nurses, respondents must have a Bachelor of Nursing Sciences degree or a higher national diploma in nursing

  4. Respondent must be a permanent staff member of OAUTHC.

Exclusion criteria

  1. Medical practitioners who are not doctors, nurses, pharmacists, or physiotherapists

  2. Age <18 or more than 70.

Sampling technique/sample size

This study followed a convenience sampling approach.[22] The sample size was determined using the standard formula for a quantitative cross-sectional study. The formula for sample size was given as

N=Zα+22×p×1P×DE2

Where N = Sample size

P = Prevalence of event

E = Precision of error

D = Design effect

Zα+22 = 1.96 (for alpha of 0.05).

Although there is a dearth in studies on knowledge of malaria vaccines among health professionals in Nigeria, it is expected to be higher than that of the public and other policymakers.[23,24] Therefore, a 50% awareness level is expected. Using a 95% confidence interval and a design effect of 1 for simple random sampling, the calculated sample size is given thus.

N=1.962×0.5×0.2×10.052

N = 153⋅664

This value can be approximated to 154, which is the number of respondents to be included in the study.

Data collection and instrumentation

Data collection was carried out between October and November 2023. The data were collected using online structured questionnaires with both open and closed-ended questions developed using Google Forms. The questionnaire is divided into four domains. The first domain covers sociodemographic variables such as age, sex, religion, qualifications, and years of experience. The second to fourth domains covered knowledge of the malaria vaccine, perception, and attitude. It is a semi-structured questionnaire adapted from several peer-reviewed studies.[25-30] The link to the form was shared on the hospital group and unit social media platforms.

Measurement of variables

Knowledge questions assessed healthcare workers’ awareness, familiarity, and understanding of the malaria vaccine, including their training and self-assessed expertise. Four questions (Q9-Q12) were included under this category:

Responses were scored on a binary scale (e.g., Yes = 1, No = 0) for Q9-Q11. For Q12, a Likert scale was employed, ranging from none = 1 to high = 4. The total possible score for knowledge ranged from 1 to 7, with higher scores indicating greater knowledge. Based on the total scores, respondents were categorized as:

  • Low knowledge (1–3)

  • Moderate knowledge (4–5)

  • High knowledge (6–7).

This approach was informed by previous studies that utilized self-reported knowledge measures to assess healthcare workers’ familiarity with new health interventions.[6,17]

Attitude questions and scoring

Attitude questions measured healthcare workers’ willingness, readiness, and actions toward recommending or promoting the malaria vaccine. Three questions (Q14, Q15, Q18) were included:

Responses for all three questions were scored on a binary scale (Yes = 1, No = 0). The total attitude score ranged from 0 to 3, with respondents categorized as:

  • Negative attitude: 1–2

  • Neutral attitude: 3

  • Positive attitude: 4–5.

This binary scoring was based on prior research where attitudes toward vaccines were assessed using direct questions about willingness to recommend and support immunization programs.[18,31]

Data analysis

The data obtained from the online questionnaires was downloaded as a spreadsheet. Data cleaning was done using MS Excel 2021. Thereafter, the data were analyzed using International business machine’s statistical package for the social sciences (IBM-SPSS) version 24. The respondent characteristics, knowledge, and attitude were analyzed and presented as descriptive statistics (frequencies and percentages). Further inferential analyses using Chi-square tests were carried out to determine the association of selected sociodemographic characteristics with knowledge levels and attitudes toward the malaria vaccine [Table 4]. Spearman’s ranked correlation test was used to test the relationship between knowledge and attitude. The results were visualized in charts and tables using MS Excel software.

Data quality control

Before the data collection, the questionnaires were pretested on 5% of the total sample size on healthcare service providers in a different facility, which is not part of the sample population. Based on the findings of the pretest, modifications were made to the data collection instruments.

RESULTS

Sociocultural demographic information

The study surveyed a total of 154 healthcare workers. Due to the method of distribution of the questionnaires, the study had a 100% response rate. The majority of respondents were between the ages of 29–39 years. The study had more female respondents, but the distribution was even among the married and the unmarried. Christianity was the predominant religion among the respondents.

Although the professional distribution was skewed toward pharmacists (64.94%), the respondents’ years of professional experience were diverse, with the largest group having 5–10 years of experience (40.26%). Nearly half of the respondents (43.51%) had been working in the facility for <2 years [Table 1].

Table 1: Sociodemographic information.
Variables n=154 Percentage
Age group of respondents
  18–28 58 37.66
  29–39 87 56.49
  40–49 7 4.55
  50 and above 2 1.30
Sex
  Male 69 44.81
  Female 85 55.19
Marital status
  Never married 74 48.05
  Married 79 51.30
  Cohabiting 1 0.65
Religion
  Christian 139 90.26
  Muslim 14 9.09
  Others 1 0.65
Professional training
  Doctors 42 27.27
  Pharmacist 100 64.94
  Nurses 6 3.90
  Physiotherapist 6 3.90
Years of professional experience
  <1 year 22 14.29
  1–3 years 25 16.23
  3–5 years 33 21.43
  5–10 years 62 40.26
  More than 10 years 12 7.79
For how long have you been working in this health facility?
  1–2 years 67 43.51
  3–5 years 57 37.01
  6–10 years 25 16.23
  Above 10 years 5 3.25

Table 2 shows that the majority of the participants (84.42%) had heard of the existence of a vaccine. However, only 11.04% had received any form of malaria vaccine training. Consequently, about 87% reported their knowledge of the vaccine as less than average. Interestingly, 49.35% were not sure of its preventive effect [Table 2].

Table 2: Knowledge of health professionals on the currently available malaria vaccine.
Variables n=154 Percentage
Have you heard of the malaria vaccine?
  No 24 15.58
  Yes 130 84.42
Have you received any formal training or information on the malaria vaccine?
  No 137 88.96
  Yes 17 11.04
Have you received any formal training on malaria vaccine implementation?
  No 145 94.16
  Yes 9 5.84
How would you rate your knowledge of the malaria vaccine?
  None 72 46.75
  Low 62 40.26
  Moderate 16 10.39
  High 4 2.60
Do you believe that the malaria vaccine is effective in preventing malaria?
  No 6 3.90
  Yes 72 46.75
  Not sure 76 49.35
Have you been involved in administering or recommending the malaria vaccine?
  No 144 93.51
  Yes 10 6.49

From Table 3, the respondents report positive attitudes about the malaria vaccine, attesting to its effectiveness and recommending its use. However, the confidence for counseling and health education was low (35.06%) despite 82.47% of respondents agreeing to the necessity of the vaccine. This dissonance between knowledge and need is seen as 82% agreed to the notion that access to training would positively impact attitude and perception [Table 3].

Table 3: Attitude of health professionals toward malaria vaccine.
Variables n=154 Percentage
Would you recommend the malaria vaccine to your patients?
  No 15 9.74
  Yes 139 90.26
Do you support including the malaria vaccine in the national immunization program?
  No 1 0.65
  Yes 140 90.91
  Not sure 13 8.44
How confident do you feel about discussing the benefits of the malaria vaccine with patients?
  Not so confident 31 20.13
  Moderately confident 69 44.81
  Very confident 54 35.06
Do you believe that the malaria vaccine is necessary for preventing malaria in high-risk areas?
  No 4 2.60
  Yes 127 82.47
  Not sure 23 14.94
Do you believe that access to training and resources affects your perception of the malaria vaccine?
  Strongly disagree 6 3.90
  Disagree 1 0.65
  Neutral 21 13.64
  Agree 47 30.52
  Strongly agree 79 51.30

Figure 1 shows the expected challenges to the adoption and administration of malaria vaccine interventions in Nigeria. Chief among these was the lack of education/training. Hesitancy among health professionals was not considered a major barrier by the respondents. However, they still had concerns regarding efficacy, safety, and costs [Figure 2].

Perceived implementation challenges for the malaria vaccine program. This figure visualizes perceived challenges that the respondents perceive will be faced during the implementation of the malaria vaccine program in Nigeria.
Figure 1:
Perceived implementation challenges for the malaria vaccine program. This figure visualizes perceived challenges that the respondents perceive will be faced during the implementation of the malaria vaccine program in Nigeria.
Concerns of healthcare workers regarding the malaria vaccine. As part of the study, the respondents were asked to report concerns regarding the use of the approved malaria vaccines. This bar visualizes the results, allowing for the ranking of perceived concerns.
Figure 2:
Concerns of healthcare workers regarding the malaria vaccine. As part of the study, the respondents were asked to report concerns regarding the use of the approved malaria vaccines. This bar visualizes the results, allowing for the ranking of perceived concerns.

A Chi-square test was used to test the association between respondent characteristics and their level of knowledge on the vaccine. None of the sociodemographic variables was significantly associated with knowledge levels [Table 4].

Table 4: Association between sociodemographic variables and knowledge of health workers.
Variables Knowledge of the vaccine Chi-square df P-value
Low knowledge Average knowledge High knowledge
Age
  18–28 49 (84.5) 6 (10.3) 3 (5.2) 4.472 6 0.613
  29–39 71 (81.6) 13 (14.9) 3 (3.4)
  40–49 4 (57.1) 2 (28.6) 1 (14.3)
  50–50+ 2 (100) 0 (0) 0 (0)
Gender
  Male 61 (88.4) 6 (8.7) 2 (2.9) 3.647 2 0.161
  Female 65 (76.5) 15 (17.6) 5 (5.9)
Years of professional experience
  <1 year 18 (81.8) 2 (9.1) 2 (9.1) 6.741 8 0.565
  1–3 years 22 (88) 3 (12) 0
  3–5 years 29 (87.9) 2 (6.1) 2 (6.1)
  5–10 years 47 (75.8) 12 (17.4) 3 (4.8)
  >10 years 10 (83.3) 2 (16.7) 0
Cadre of professional training
  Medical doctors 37 (88.1) 4 (9.5) 1 (2.4) 7.101 6 0.312
  Pharmacists 80 (80) 15 (15) 5 (5)
  Nurses 3 (50) 2 (33.3) 1 (16.7)
  Physiotherapists 6 (100) 0 (0) 0 (0)
Religion
  Christian 115 (82.9) 18 (12.7) 6 (4.3) 1.316 4 0.859
  Muslim 10 (71.4) 3 (12.4) 1 (7.1)
  Other 1 (100) 0 (0) 0 (0)

Statistically significant at P<0.05, *indicates statistical significance and that P<0.05.

Similarly, a Chi-square test was used to determine the association between sociodemographic variables and the attitude of healthcare workers toward the vaccine. Only religion was shown to have a significant relationship with respondents’ attitudes [Table 4].

DISCUSSION

Knowledge of healthcare workers on the malaria vaccine

This study aimed to assess healthcare workers’ knowledge of the malaria vaccine. The findings showed that most respondents had limited knowledge of the malaria vaccine. This aligns with previous research identifying significant gaps in understanding among healthcare workers regarding malaria vaccines, especially in sub-Saharan Africa.[6,17] Although many healthcare workers knew about the existence of malaria vaccines, there was a lack of understanding about their mechanisms of action, effectiveness, and recommended use.

This is concerning, as these professionals are responsible for educating the public, administering vaccines, and advocating for their use.[32] Healthcare workers may not feel sufficiently prepared to promote the malaria vaccine, which could impede the success of vaccination programs. Conversely, healthcare workers in OAUTHC demonstrated a high level of knowledge about the COVID-19 vaccine, likely due to targeted efforts to educate healthcare workers about COVID-19 vaccination.[33,34]

High vaccine knowledge has previously been linked to exposure to the disease and vaccination, a pattern observed with older vaccine-preventable diseases such as polio and yellow fever.[34,35] The respondents also reported a lack of training or involvement in vaccination efforts. Therefore, this study emphasizes the need for targeted educational interventions among health workers. The strong association between healthcare workers’ access to training and their knowledge, perceptions, and attitudes toward the malaria vaccine underscores the urgent need for targeted and equitable training programs. Training should not only address vaccine efficacy and safety but also focus on improving healthcare workers’ confidence in communicating the vaccine’s benefits to patients, paying attention to significant religious influences. An understanding of the vital role healthcare workers’ knowledge plays in ensuring the success of vaccination programs, especially in resource-limited settings like Nigeria, is crucial, as low knowledge levels are directly associated with acceptance and implementation.[6,17] These interventions should be designed to address misconceptions and behaviors as well as to improve clinical knowledge.

Attitudes of healthcare workers toward recommendation and implementation

Assessing attitudes toward the vaccines, the results show a positive attitude among healthcare workers, particularly regarding their inclusion in the national immunization program. However, they perceive inadequate funding and logistical challenges as major obstacles to the vaccine’s rollout.[36,37] Cultural barriers and hesitancy among healthcare workers were not regarded as significant [Figure 1]. Previous studies have found generally positive views toward vaccination among healthcare workers, especially in regions with high malaria burdens, suggesting that culture and religion are lesser determinants within this demographic.[31,38]

Conversely, Bakare reported high levels of hesitancy and low confidence for new vaccines among healthcare workers in Nigeria.[35] Hesitancy was recognized with newer vaccines such as COVID-19, hepatitis B, and human papillomavirus. This hesitancy was attributed mainly to safety concerns and low understanding of long-term effects, an outcome that was also observed in the present study. Despite expressing strong support for the malaria vaccine, their confidence in discussing the benefits of the vaccine with patients was widely varied. Further analysis showed this attitude to be correlated with knowledge of the vaccine. As in similar studies, the respondents were likely to recommend the vaccine if they believed it to be effective.[19] In addition, access to training was strongly associated with more favorable perceptions of the vaccine, as trained healthcare workers were better able to understand and advocate for its benefits.

Addressing vaccine hesitancy and safety concerns remains a priority. Evidence-based communication strategies should be implemented to counter misinformation and build trust. Collaboration with religious and community leaders is essential to tailor these campaigns to local cultural and social contexts, particularly in rural areas. In addition, research could focus on assessing the effectiveness of tailored training programs and community engagement initiatives in improving vaccine knowledge and uptake.

Concerns regarding malaria vaccine use and program implementation

The majority of the respondents expressed concerns about the safety of the malaria vaccine, with common concerns including short-term and long-term side effects, efficacy, and insufficient clinical trials. Research on vaccine hesitancy identifies safety concerns as a major factor contributing to reluctance toward vaccine acceptance.[18,19] Unlike the COVID-19 vaccine, the malaria vaccines have undergone lengthy and thorough clinical trials with proven efficacy and minimal side effects.[13,39] The existing doubts are further confirmation of poor knowledge of the malaria vaccines [Table 5]. However, as a novel intervention, there is relatively limited data on long-term effectiveness and safety. Efforts to improve vaccine logistics, particularly storage and transportation, are critical. Investments in cold chain systems and outreach infrastructure are necessary to ensure that the malaria vaccine reaches remote regions without compromising its therapeutic potency. Investigating the role of systemic barriers, such as policy inconsistencies and resource constraints, could also provide actionable insights to strengthen vaccine rollout strategies in Nigeria.

Table 5: Association between sociodemographic variables and attitude of health care workers toward the malaria vaccine.
Variables Attitude toward the vaccine Chi-square df P-value
Negative attitude Neutral attitude Positive attitude
Age
  18–28 5 (8.6) 6 (10.3) 47 (81) 4.725 6 0.586
  29–39 3 (3.4) 5 (5.7) 79 (90.8)
  40–49 1 (14.3) 0 (0) 6 (85.7)
  50–50+ 0 (0) 0 (0) 2 (100)
Gender
  Male 61 (88.4) 6 (8.7) 2 (2.9) 0.455 2 0.797
  Female 5 (5.9) 5 (5.9) 75 (88.2)
Years of professional experience
  <1 year 2 (9.1) 1 (4.5) 19 (86.4) 3.901 8 0.866
  1–3 years 0 (0) 3 (12) 22 (88)
  3–5 years 3 (9.1) 2 (6.1) 8 (84.8)
  5–10 years 3 (4.8) 4 (6.5) 55 (88.7)
  >10 years 1 (8.3) 1 (8.3) 10 (83.3)
Cadre of professional training
  Medical doctors 5 (11.9) 2 (4.8) 35 (83.3) 5.752 6 0.425
  Pharmacists 4 (4) 8 (8) 88 (88)
  Nurses 0 (50) 0 (0) 6 (100)
  Physiotherapists 0 (0) 1 (16.7) 5 (83.3)
Religion
  Christian 9 (6.5) 12 (7.2) 140 (86.3) 1.316 4 0.004*
  Muslim 0 (0) 0 (0) 14 (100)
  Other 0 (0) 1 (100) 0 (0)

Statistically significant at P<0.05, *indicates statistical significance and that P<0.05.

Association between sociodemographic variables and knowledge or attitude

The analysis revealed no significant association between age, gender, religion, cadre of professional training, or years of experience with knowledge of malaria vaccine. This could be due to the research criteria that included only medical doctors, pharmacists, nurses, and physiotherapists, professions that have equal access to vaccine information.[38] Although a higher percentage of respondents with more years of experience had higher levels of knowledge, this difference was not statistically significant (NO_PRINTED_ FORM) (NO_PRINTED_FORM). It can be inferred that since all respondents were educated and within similar earning statuses, wealth and education do not influence knowledge and, by extension, attitude, contrary to evident reports.[40]

Limitations

Self-selection is a common bias associated with online questionnaires.[41] It was possible that individuals who did not meet the inclusion criteria filled out the questionnaire. Therefore, the data were cleaned to optimize validity. Another limitation was the cadre imbalance and small subgroup sizes, skewing the data and affecting the ability to run the necessary inferential analysis. Furthermore, this may lead to overrepresentation of respondents with similar views on vaccines.

The single-center focus and the exclusion of primary health care and some allied health professionals limit generalizability.[42] Although a convenience sample was used, small sample sizes may be acceptable when the effect size under investigation is presumably large or when the researcher aims to determine the presence of an effect only and not the effect size.[43] In this study, the aim was to identify associations only, making this method suitable for the study.

CONCLUSION

This study highlights a critical gap in healthcare workers’ knowledge of the malaria vaccine despite generally positive attitudes toward it. Although awareness of the vaccine is high, an understanding of its efficacy, mechanism, and safety remains limited. This knowledge gap poses a challenge to the proposed rollout and implementation of the vaccination program, given the pivotal role that healthcare workers play in education and advocacy. Therefore, there is a need to design targeted training programs that provide not only technical knowledge but also address behavioral barriers driven by religion and culture. The lack of statistical association between sociodemographic variables and knowledge underscores the widespread lack of information. In addition, logistical and financial barriers must be addressed to improve confidence in the vaccines. By enhancing competence and confidence, the promotion of the malaria vaccine uptake and sustenance of public trust can be achieved.

Ethical approval:

The research/study was approved by the Institutional Review Board at (1). University of Sunderland in London, UK (2). Obafemi Awolowo University Teaching Hospital Complex, Ile-Ife, Osun State, Nigeria, approval number (1). 029414 (2). ERC/2024/11/06, dated (1). December 12, 2024 (2). 11th December 2024.

Declaration of patient consent:

Patient’s consent is not required as there are no patients in this study.

Conflicts of interest:

There are no conflicts of interest.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation:

The author confirms that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

Financial support and sponsorship: None.

References

  1. , . Acceptance and affordability of malaria vaccines: Issues relating to hesitancy and willingness to pay amongst Nigerian parents of under-five children. Malar J. 2025;24:36. doi: https://doi-org.proxy2.library.illinois.edu/10.1186/s12936-025-05268-y
    [CrossRef] [PubMed] [Google Scholar]
  2. World Health Organization. . Malaria. [accessed 2025 Aug 02] https://www.who.int/news-room/fact-sheets/detail/malaria
    [Google Scholar]
  3. , , , et al. The economic burden of malaria on households and the health system in Enugu State southeast Nigeria. PLoS One. 2013;8:e78362. doi: https://doiorg.proxy2.library.illinois.edu/10.1371/journal.pone.0078362
    [CrossRef] [PubMed] [Google Scholar]
  4. , , . Patronage and cost of malaria treatment in private hospitals in Ibadan north L.G.A south western, Nigeria. Ann Ib Postgrad Med. 2016;14:81-4.
    [Google Scholar]
  5. , , , et al. A cross-sectional study of the prevalence, density, and risk factors associated with malaria transmission in urban communities of Ibadan, Southwestern Nigeria. Heliyon. 2021;7:e05975. ISSN 2405-8440, doi: 10.1016/j.heliyon.2021.e05975
    [CrossRef] [PubMed] [Google Scholar]
  6. , , , et al. Awareness, perceptions and intent to comply with the prospective malaria vaccine in parts of South Eastern Nigeria. Malar J. 2018;17:187. doi: https://doi-org.proxy2.library.illinois.edu/10.1186/s12936-018-2335-0
    [Google Scholar]
  7. , , , et al. Economic and resource use associated with management of malaria in children aged <5 years in sub-Saharan Africa: A systematic literature review. MDM Policy Pract. 2019;4:5. doi: https://doiorg.proxy2.library.illinois.edu/10.1177/2381468319893986
    [CrossRef] [PubMed] [Google Scholar]
  8. , , . A propensity score matching analysis using statistical methods for estimating the impact of intervention: The cost of malaria and its impact on the health system. Healthc Anal. 2023;4:100246. doi: 10.1016/j.health.2023.100246
    [CrossRef] [Google Scholar]
  9. . Malaria. . [accessed 2025 Aug 02] https://ncdc.gov.ng/diseases/factsheet/24
    [Google Scholar]
  10. , , , et al. Adherence to malaria diagnosis and treatment guidelines among healthcare workers in Ogun State, Nigeria. BMC Public Health. 2016;16:828. doi: https://doi-org.proxy2.library.illinois.edu/10.1186/s12889-016-3495-x
    [CrossRef] [PubMed] [Google Scholar]
  11. . Malaria incidence (per 1000 population at risk) estimate. . The Global Health Observatory. [accessed 2025 Aug 02] https://www.who.int/data/gho/data/indicators/indicator-details/GHO/malaria-incidence-(per-1-000-population-at-risk)
    [Google Scholar]
  12. . WHO recommends groundbreaking malaria vaccine for children at risk. . [accessed 2025 Aug 02] https://www.who.int/news/item/06-10-2021-who-recommends-groundbreaking-malaria-vaccinefor-children-at-risk
    [Google Scholar]
  13. . Malaria vaccines (RTS S and R21) . [accessed 2025 Aug 02] https://www.who.int/news-room/questions-and-answers/item/q-a-on-rts-s-malaria-vaccine
    [Google Scholar]
  14. , . A new landscape for malaria vaccine development. PLoS Pathog. 2024;20:e1012309. doi: https://doi-org.proxy2.library.illinois.edu/10.1371/journal.ppat.1012309
    [CrossRef] [PubMed] [Google Scholar]
  15. , , , et al. Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: A multicentre, double-blind, randomised, phase 3 trial. Lancet. 2024;403:533-44. doi: https://doi-org.proxy2.library.illinois.edu/10.1016/S0140-6736(23)02511-4
    [Google Scholar]
  16. . Shipment of newest malaria vaccine, R21, to Central African Republic marks latest milestone for child survival. . [accessed 2025 Aug 02] https://www.who.int/news/item/24-05-2024-shipment-of-newest-malaria-vaccine--r21--to-central-african-republic-marks-latest-milestone-for-child-survival
    [Google Scholar]
  17. , , , et al. Prospects of malaria vaccination in Nigeria: Anticipated challenges and lessons from previous vaccination campaigns. Ann Med Surg (Lond). 2022;81:104385. ISSN 2049-0801, doi: 10.1016/j.amsu.2022.104385
    [CrossRef] [PubMed] [Google Scholar]
  18. . Parallel dilemmas: Polio transmission and political violence in northern Nigeria. Africa. 2014;84:466-86. doi: 10.1017/S0001972014000369
    [CrossRef] [Google Scholar]
  19. , , , et al. When it is available, will we take it? Social media users' perception of hypothetical COVID-19 vaccine in Nigeria. Pan Afr Med J. 2021;38:230. doi: https://doi-org.proxy2.library.illinois.edu/10.11604/pamj.2021.38.230.27325
    [CrossRef] [PubMed] [Google Scholar]
  20. , . Cross-sectional studies: Strengths, weaknesses, and recommendations. Chest. 2020;158:S65-71. doi: 10.1016/j.chest.2020.03.012. 32658654
    [CrossRef] [PubMed] [Google Scholar]
  21. . Panel indicts OAUTH ex-CMD of massive job racketeering. . Punch. [accessed 2025 Aug 02] https://punchng.com/panel-indicts-oauth-ex-cmd-of-massive-jobracketeering/#google_vignette
    [Google Scholar]
  22. , . Sampling methods in clinical research; an educational review. Emerg (Tehran). 2017;5:e52.
    [CrossRef] [Google Scholar]
  23. , , , et al. Evaluating the knowledge, attitude, perception, and readiness of caregivers of under 5-year-old children to accept malaria vaccine in Nigeria. Clin Exp Vaccine Res. 2024;13:121-31. doi: https://doi-org.proxy2.library.illinois.edu/10.7774/cevr.2024.13.2.121
    [CrossRef] [PubMed] [Google Scholar]
  24. , . Perception and awareness towards malaria vaccine policy implementation in Nigeria by health policy actors. Malar J. 2023;22:111. doi:10.1186/s12936-023-04536-z
    [CrossRef] [PubMed] [Google Scholar]
  25. , , , et al. Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination. PLoS One. 2018;13:e0208601. doi: https://doi-org.proxy2.library.illinois.edu/10.1371/journal.pone.0208601
    [CrossRef] [PubMed] [Google Scholar]
  26. , , , et al. Mapping vaccine hesitancy--Country-specific characteristics of a global phenomenon. Vaccine. 2014;32:6649-54. doi: 10.1016/j.vaccine.2014.09.039
    [CrossRef] [PubMed] [Google Scholar]
  27. , , . The psychological roots of anti-vaccination attitudes: A 24-nation investigation. Health Psychol. 2018;37:307-15.
    [CrossRef] [PubMed] [Google Scholar]
  28. , . Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33:4161-4. doi: 10.1016/j.vaccine.2015.04.036
    [CrossRef] [PubMed] [Google Scholar]
  29. , , , et al. Vaccine hesitancy: Causes, consequences, and a call to action. Am J Prev Med. 2015;49(Suppl 6):S391-8. doi: 10.1016/j.vaccine.2015.09.035
    [CrossRef] [PubMed] [Google Scholar]
  30. , , , et al. Attitudes to vaccination: A critical review. Soc Sci Med. 2014;112:1-11. doi: 10.1016/j.socscimed.2014.04.018
    [CrossRef] [PubMed] [Google Scholar]
  31. , , , et al. Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review. Immun Inflamm Dis. 2023;11:e899. doi: 10.1002/iid3.899
    [CrossRef] [PubMed] [Google Scholar]
  32. , , , et al. Population and vaccine hesitancy: A demographic and Socio-behavioural examination of a barrier to Covid-19 herd immunity in Nigeria. Sci Afr. 2023;19:e01508. doi: 10.1016/j.sciaf.2022.e01508
    [CrossRef] [PubMed] [Google Scholar]
  33. , , , et al. COVID-19 vaccine education (CoVE) for health and care workers to facilitate global promotion of the COVID-19 vaccines. Int J Environ Res Public Health. 2022;19:653. doi:10.3390/ijerph19020653
    [CrossRef] [PubMed] [Google Scholar]
  34. , , , et al. An assessment of COVID-19 vaccine knowledge and acceptability among healthcare workers in a Nigerian tertiary hospital. Ghana Med J. 2023;57:284-92. doi: 10.4314/gmj.v57i4.5
    [CrossRef] [PubMed] [Google Scholar]
  35. , , , et al. "It's easier to deal with the vaccines you know than the ones you don't know": A qualitative study on healthcare workers' vaccine confidence in Nigeria. Vaccine. 2025;55:127020. doi: 10.1016/j.vaccine.2025.127020
    [CrossRef] [PubMed] [Google Scholar]
  36. , , , et al. urrent state and challenges of local production of vaccines in Nigeria. Public Health Chall. 2024;3:e70006. doi:10.1002/puh2.70006
    [CrossRef] [PubMed] [Google Scholar]
  37. , , , et al. Medicines and vaccines supply chains challenges in Nigeria: A scoping review. BMC Public Health. 2022;22:11. doi: 10.1186/s12889-021-12361-9
    [CrossRef] [PubMed] [Google Scholar]
  38. , , , et al. Malaria vaccine efficacy, safety, and community perception in Africa: A scoping review of recent empirical studies. Infection. 2024;52:2007-28. doi: https://doi-org.proxy2.library.illinois.edu/10.1007/s15010-024-02196-y
    [CrossRef] [PubMed] [Google Scholar]
  39. , , . Recent perspectives in clinical development of malaria vaccines. Nat Commun. 2025;16:3565. doi: 10.1038/s41467-025-58963-4
    [CrossRef] [PubMed] [Google Scholar]
  40. , , , et al. Vaccine equity in low and middle income countries: A systematic review and meta-analysis. Int J Equity Health. 2022;21:82. doi: 10.1186/s12939-022-01678-5
    [CrossRef] [PubMed] [Google Scholar]
  41. . The limitations of online surveys. Indian J Psychol Med. 2020;42:575-6. doi:10.1177/0253717620957496
    [CrossRef] [PubMed] [Google Scholar]
  42. , , , et al. Assessing the level of knowledge, uptake of hepatitis B virus vaccine, and its determinants among health workers across various levels of health facilities in Ondo, South West, Nigeria. Egypt J Intern Med. 2022;34:80. doi: 10.1186/s43162-022-00167-z
    [CrossRef] [Google Scholar]
  43. , . The importance of small samples in medical research. J Postgrad Med. 2021;67:219-23. doi:10.4103/jpgm.JPGM_230_21
    [CrossRef] [PubMed] [Google Scholar]
Show Sections